Canquan Mao
Key Laboratory Of Advanced Materials Technology
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
A Fluorinated Dual-Functional Nanoassembly Induces Potent Antitumor Immunity via Programmable PD-L1 Suppression.
Journal: Advanced healthcare materials
Published: April 14, 2026
Deciphering the immunomodulatory code: how metal nanoadjuvants orchestrate intracellular immune signaling cascades.
Journal: Biochemical pharmacology
Published: January 20, 2026
A peptide-based PROTAC targeting FOXM1 suppresses fibrosis-associated hepatocarcinogenesis.
Journal: Theranostics
Published: December 07, 2025
GPCR signaling from endosome: mechanistic insights and therapeutic potentials.
Journal: European journal of pharmacology
Published: August 12, 2025
Overexpression of OsLTSD2 decreases cold tolerance in rice.
Journal: Plant biology (Stuttgart, Germany)
Published: July 28, 2025
Manganese oxide nanoparticle acts as a promising immune adjuvant via tuning ferroptosis signaling.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 08, 2025
A novel designed fully peptide-based PROTAC, FPP29, demonstrates its potent cytotoxic effects to liver cancer HCCLM3 cells by targeting FOXM1.
Journal: Bioorganic chemistry
Published: March 25, 2025
Dissecting the multi-omics landscape of TEAD1 in hepatocellular carcinoma: cycle regulation and metastatic potential.
Journal: Frontiers in immunology
Published: January 28, 2025
Identification and characterization of a potent peptide inhibitor targeting FOXM1 in cancer therapy.
Identification and characterization of a potent peptide inhibitor targeting FOXM1 in cancer therapy.
Journal: Biochemical pharmacology
Published: January 06, 2025
Polysaccharide nanoparticles as potential immune adjuvants: Mechanism and function.
Journal: Acta pharmaceutica Sinica. B
Published: November 04, 2024
A novel peptide CP29L, selected from the phage displayed cyclic random heptapeptide library, demonstrates its potent inhibitory effects to liver cancer HCCLM3 cells by targeting FOXM1.
Journal: European journal of pharmacology
Published: August 09, 2024
Dual-functional Nanosized Albumin Facilitates CRISPR-Cas9-PAR2 to Mitigate Cytokine Storm via TLR4 and Pyroptosis Signaling.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: July 05, 2024
Last Updated: 09/26/2026